Somatus, a McLean, Va.-based market leader in value-based kidney care, raised $64m in Series C funding round.
The round, which brought the total capital raised to over $105m since its launch in 2016, was led by Longitude Capital and co-led by Optum Ventures and Deerfield Management Company, with participation from existing investors Blue Venture Fund, Flare Capital, and Town Hall Ventures.
The company intends to use the funds to continue to scale its model nationally and invest in technology and product development.
Led by Co-Founder and CEO Ikenna Okezie, MD, Somatus partners with health plans, health systems, and nephrology and primary care groups to provide integrated care for patients with or at risk of developing kidney disease.
Its vertically integrated clinical services and technology aims to delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation.
The Somatus model uses actionable intelligence from propriety platform to power field-based care team efforts and connect major kidney care stakeholders. Multiple data sets are used to predict undiagnosed disease as well as the severity and velocity of disease progression, utilization, and the likelihood of an unplanned dialysis start. A team of renal clinicians and community-based team members use evidence-based care pathways and personalized outreach to develop a care plan focused on helping members achieve kidney health.
The company now provides kidney care services to more than 20,000 chronic kidney disease and end-stage kidney disease patients across six states.